ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial tests experimental treatment for tough tumors
Disease control Recruiting nowThis early-stage study is testing whether an experimental drug called NRM-823 is safe and can help control advanced cancers that have stopped responding to standard treatments. Researchers will give NRM-823 alone and combined with immunotherapy to about 150 adults with various so…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough cancers: first human test of experimental drug begins
Disease control Recruiting nowThis is an early-stage study to test the safety and find the right dose of a new experimental drug, JAB-8263, in adults with advanced cancers that have not responded to standard treatments. The trial will enroll about 152 people with various advanced solid tumors (like lung or ov…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First patients to receive new 'Smart Bomb' cancer drug in groundbreaking trial
Disease control Recruiting nowThis is the first study in people to test a new experimental cancer drug called ALX2004. It aims to find a safe dose and see if the drug can help control advanced cancers that have spread and stopped responding to other treatments. The trial will enroll about 170 adults with spec…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Triple-Threat attack on esophageal cancer before surgery
Disease control Recruiting nowThis study is testing a new treatment plan for people with a type of advanced esophageal cancer. The goal is to see if using a combination of immunotherapy and chemotherapy, followed by radiation and chemotherapy, all before surgery, can better shrink or eliminate the tumor. Rese…
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New blood test could spot deadly cancer earlier, without invasive scopes
Diagnosis Recruiting nowThis study is developing a simple blood test to find esophageal cancer early, when it's most treatable. Researchers will analyze tiny genetic markers in the blood of 600 people, comparing those with and without cancer. The goal is to create a test that is less invasive and more a…
Matched conditions: ESCC
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC